This inventor holds 1 USPTO granted patent. Top assignee: Oregon Health & Science University. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Fronziska Ruchti: Innovator in Cell Migration Research
Introduction
Fronziska Ruchti is a notable inventor based in Portland, OR (US). He has made significant contributions to the field of medical research, particularly in the area of cell migration and its implications for various diseases.
Latest Patents
Ruchti holds a patent titled "Prevention of cell migration initiation with CMV US28 receptor antagonists." This patent discloses an assay system for determining therapeutic activity for treating conditions such as restenosis, atherosclerosis, chronic rejection syndrome, and graft versus host disease (GVHD). The invention outlines methods for measuring inhibition of cell migration in smooth muscle cells expressing a US28 receptor from the CMV genome. It also provides a method for treating these conditions by administering an effective amount of a US28 receptor antagonist.
Career Highlights
Ruchti is affiliated with Oregon Health & Science University, where he conducts research that bridges the gap between basic science and clinical applications. His work has the potential to impact the treatment of serious health conditions, showcasing his commitment to advancing medical knowledge.
Collaborations
Ruchti has collaborated with esteemed colleagues such as Daniel Streblow and Jay A Nelson. These partnerships have likely enriched his research and contributed to the development of innovative solutions in his field.
Conclusion
Fronziska Ruchti's work exemplifies the intersection of innovation and medical research. His contributions to understanding cell migration and its therapeutic implications are invaluable to the scientific community.